Sutro Biopharma Stock Momentum Indicators Ultimate Oscillator

STRO Stock  USD 2.51  0.02  0.79%   
Sutro Biopharma momentum indicators tool provides the execution environment for running the Ultimate Oscillator indicator and other technical functions against Sutro Biopharma. Sutro Biopharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Ultimate Oscillator indicator function is designed to identify and follow existing trends. Momentum indicators of Sutro Biopharma are pattern recognition functions that provide distinct formation on Sutro Biopharma potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify First Period, Second Period and Third Period to execute this model.

The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Ultimate Oscillator is a smoothing indicator that uses the weighted average of Sutro Biopharma three different time periods to reduce the effects of volatility and false trends of Sutro Biopharma price series.

Sutro Biopharma Technical Analysis Modules

Most technical analysis of Sutro Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sutro from various momentum indicators to cycle indicators. When you analyze Sutro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sutro Biopharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sutro Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sutro Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Sutro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sutro Biopharma's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Sutro Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Sutro Biopharma, we also check how macroeconomic factors affect Sutro Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number17.0415.049.979.47
Receivables Turnover4.979.524.264.05
Hype
Prediction
LowEstimatedHigh
0.152.938.08
Details
Intrinsic
Valuation
LowRealHigh
0.946.0911.24
Details
Naive
Forecast
LowNextHigh
0.041.867.01
Details
11 Analysts
Consensus
LowTargetHigh
15.3716.8918.75
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Sutro Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sutro Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sutro Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sutro Biopharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.55)
Revenue Per Share
2.253
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.18)
Return On Equity
(1.11)
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.